Bronchiolitis

被引:341
作者
Smyth, Rosalind L. [1 ]
Openshaw, Peter J. M.
机构
[1] Univ Liverpool, Alder Hey Childrens Hosp, Sch Reprod & Dev Med, Div Child Hlth, Liverpool L12 2AP, Merseyside, England
[2] Imperial Coll, Natl Heart & Lung Inst, Sect Resp Infect, London, England
关键词
RESPIRATORY-SYNCYTIAL-VIRUS; NONSTRUCTURAL PROTEINS NS1; EVIDENCE-BASED GUIDELINE; HUMAN METAPNEUMOVIRUS; PERIPHERAL-BLOOD; DISEASE SEVERITY; YOUNG-CHILDREN; EMERGENCY-DEPARTMENTS; EPITHELIAL-CELLS; VIRAL-INFECTION;
D O I
10.1016/S0140-6736(06)69077-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchiolitis is a distressing, potentially life-threatening respiratory condition that affects young babies. Around 2-3% of all infants younger than 1 year are admitted to hospital with bronchiolitis, usually during the seasonal epidemic. The majority of these infants are infected with respiratory syncytial virus and all have an intense inflammatory response in their airways. Although most infants recover, they have an increased risk of recurrent wheezing. Although bronchiolitis is common, little is known about what causes infants to be susceptible. Diagnostic interventions have little effect on clinical outcome, and apart from supportive measures, there is no specific treatment. Bronchiolitis therefore presents an intriguing clinical conundrum and a major challenge to researchers. High quality clinical studies are needed to clarify assessment of disease severity and criteria for hospital admission, particularly the use of pulse oximetry and chest radiography. Careful mapping of the inflammatory pathways in the pathogenesis of bronchiolitis should lead to development of new therapies to alleviate symptoms.
引用
收藏
页码:312 / 322
页数:11
相关论文
共 118 条
  • [1] Single versus dual respiratory virus infections in hospitalized infants -: Impact on clinical course of disease and interferon-γ response
    Aberle, JH
    Aberle, SW
    Pracher, E
    Hutter, HP
    Kundi, M
    Popow-Kraupp, T
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (07) : 605 - 610
  • [2] [Anonymous], COCHRANE DATABASE SY
  • [3] Respiratory syncytial virus infection suppresses IFN-γ production of γδ T cells
    Aoyagi, M
    Shimojo, N
    Sekine, K
    Nishimuta, T
    Kohno, Y
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 131 (02) : 312 - 317
  • [4] Genetic characterization of respiratory syncytial viruses isolated from consecutive acute respiratory infections in a HIV infected child
    Arbiza, J
    Berois, M
    Delfraro, A
    Frabasile, S
    Mitoma, FD
    Milk, R
    Russi, JC
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 35 (01) : 41 - 45
  • [5] Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection
    Beyer, M
    Bartz, H
    Hörner, K
    Doths, S
    Koerner-Rettberg, C
    Schwarze, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) : 127 - 133
  • [6] Inhibition of respiratory viruses by nasally administered siRNA
    Bitko, V
    Musiyenko, A
    Shulyayeva, O
    Barik, S
    [J]. NATURE MEDICINE, 2005, 11 (01) : 50 - 55
  • [7] Boivin G, 2003, EMERG INFECT DIS, V9, P634
  • [8] Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis
    Bont, L
    Heijnen, CJ
    Kavelaars, A
    van Aalderen, WMC
    Brus, F
    Draaisma, JTM
    Geelen, SM
    van Vught, HJ
    Kimpen, JLL
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (01) : 144 - 149
  • [9] Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052
  • [10] Diagnosis and testing in bronchiolitis - A systematic review
    Bordley, WC
    Viswanathan, M
    King, VJ
    Sutton, SF
    Jackman, AM
    Sterling, L
    Lohr, KN
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2004, 158 (02): : 119 - 126